-
Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake
expresspharma
July 31, 2020
Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics.
-
Carlyle Pays $490M for 20% of Piramal Pharma
contractpharma
July 06, 2020
Will integrate Piramal Enterprises’ pharma businesses into its subsidiary Piramal Pharma Limited.
-
Tjoapack Receives Investment from Ampersand
contractpharma
April 29, 2020
Tjoapack Netherlands B.V., a global contract packaging organization (CPO) for the pharmaceutical industry, has received a majority investment from Ampersand Capital Partners.
-
Concord Medical Welcomes RMB700 Million Investment
prnasia
March 12, 2020
As the most important operating platform of Concord Medical in China, Meizhong Jiahe is focusing on the development and management of comprehensive cancer hospitals and the standalone radiotherapy and diagnostic imaging center network in China.
-
MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine
prnasia
August 06, 2019
MediBeacon Inc., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc. (NYSE MKT: HCHC), announced today that they have entered into a definitive agreement with ...
-
GSK opens new pharma manufacturing facilities with S$130M investment
biospectrumasia
July 08, 2019
New digital technology facilities and expansion of production building will boost capabilities to accelerate the supply and production of APIs for clinical trial
-
Manufacturing of paediatric medicines set to improve with new investments
europeanpharmaceuticalreview
June 24, 2019
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
-
Johns Hopkins licensed technology receives $110 M investment
biospectrumasia
June 05, 2019
A pioneering blood test developed by Johns Hopkins researchers in the US, that makes cancer detection a part of routine medical care has received the largest investment ever for a Johns Hopkins-licensed technology.
-
Investment Risks and Logic of the Bio-medicine Industry (2)
En-CPhI.cn
May 21, 2019
Characteristics of the bio-medicine industry decide that unique ideas should be employed to invest in the field...
-
Investment Risks and Logic of the Bio-medicine Industry (1)
En-CPhI.cn
May 21, 2019
The development of innovative drugs has made remarkable achievements: there have been 6 innovative drugs marketed since last year, with good news coming one after another.